In a new report by a think tank headed up by Stephen Dorrel the former health secretary (HERE) they claim we will suffer post brexit because we will be waiting longer for new drugs to be approved and UK life sciences will lose £144bn of sales by 2020. They want us to retain close ties with the European Medicines Agency.
Today we are told the UK must align its banking rules with those of the EU in order to retain access to the single market for our financial services sector (HERE).
From the outside it must look as if we are trying to rejoin with all the benefits except the two that really matter - the free movement of people and the ECJ - to the Europeans. It is as I have said before, an attempt to get what Cameron tried last year but starting from the opposite direction.
No comments:
Post a Comment